Shareholder rights law firm Robbins LLP announced on November 3, 2026, that a securities class action has been filed on behalf of investors who purchased or acquired Doximity, Inc. (NYSE:DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive.

Key Highlights

  • Class Period: The lawsuit covers investors who purchased or acquired Doximity common stock between August 8, 2024 and May 13, 2026, inclusive, according to the announcement.
  • Lead Plaintiff Deadline: Investors wishing to serve as lead plaintiff must contact Robbins LLP before November 16, 2026.
  • Three Stock Drops Alleged: The complaint describes three separate stock price declines: $8.29 per share (13%) on November 6, 2025; $5.59 per share (17%) on February 5, 2026; and $5.38 per share (23%) on May 13, 2026.
  • Core Allegation: The complaint alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share to competitors with more favorable pricing and engagement models.
  • Advertising Methods Disputed: The complaint alleges that, contrary to defendants' statements, Doximity relied heavily on both banner ads and email newsletters as advertising methods.
  • Contingency Basis: Robbins LLP states it represents investors on a contingency fee basis, meaning no upfront cost to participate.

Allegations Against Doximity and the Three Alleged Corrective Disclosures

According to the announcement from Robbins LLP, the complaint alleges that during the class period defendants characterized Doximity's Newsfeed as the company's "biggest revenue driver" and stated that growth was "led by our Newsfeed, which is both our most used and most monetized product." Defendants also reportedly told investors the Newsfeed was consistently reaching new highs, citing "an all-time record of quarterly active prescribers and double-digit growth in the number of articles read or tapped." The complaint further alleges that Doximity assured investors it does not "bombard physicians with ads and messages" and does not have "an e-newsletter product," statements the complaint characterizes as contrary to the company's actual practices.

The first alleged corrective disclosure came on November 6, 2025, when, according to the filing, Doximity "expressed a degree of caution regarding the outlook for ad spending and implied a slowdown in sales growth in the second half of the 2026 fiscal year," resulting in a stock decline of $8.29 per share, or 13%. On February 5, 2026, Doximity reportedly lowered its full fiscal year 2026 revenue guidance and announced decelerated sales growth and contracted net income, leading to an additional decline of $5.59 per share, or 17%. Analysts cited in the announcement noted that an Evercore analyst concluded that older companies such as Doximity "are losing share while programmatic, social, and other new formats are gaining share."

The third alleged corrective disclosure occurred on May 13, 2026, when Doximity reportedly missed its already-reduced revenue guidance and projected significantly slower growth for its 2027 fiscal year ending March 31, 2027. The announcement states that multiple analysts responded with downgrades, with Freeman Capital Markets describing the news as "a tough pill to swallow" and Jefferies placing the stock in the "penalty box." That disclosure was followed by a stock price decline of $5.38 per share, or 23%, according to the filing.

What Was Disclosed

Robbins LLP announced a class action complaint against Doximity, Inc. (NYSE:DOCS) alleging securities fraud related to statements about the company's Newsfeed product and competitive position between August 8, 2024 and May 13, 2026. The lead plaintiff deadline is November 16, 2026.